Literature DB >> 29587162

QA measurement of gamma-ray dose and neutron activation using TLD-400 for BNCT beam.

Wen-Chyi Tsai1, Chun-Kai Huang2, Shiang-Huei Jiang3.   

Abstract

TLD-400 (CaF2:Mn) chips were applied for the gamma-ray dose measurement in a PMMA phantom exposed to a BNCT beam because of their very low neutron sensitivity. Since TLD-400 chips possess an adequate amount of Mn activator they have been employed in this work simultaneously for neuron activation measurement. The self-irradiation TL signals owing to the decay of the neutron induced 56Mn activity have been applied for a calibration of the TLD-400 chip in situ, where the activities were measured by an HPGe detector system and the energy deposition per disintegration of 56Mn was calculated by applying a Monte Carlo code. It was accidentally found that the irradiated TLD-400 chips were capable of emitting prominent scintillation lights owing to the induced 56Mn activity, which can easily be recorded by the TLD reader without heating and after a calibration can be used to determine the 56Mn activity.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  BNCT beam; Gamma-ray dose; Neutron activation; QA measurement; TLD-400

Mesh:

Substances:

Year:  2018        PMID: 29587162     DOI: 10.1016/j.apradiso.2018.03.010

Source DB:  PubMed          Journal:  Appl Radiat Isot        ISSN: 0969-8043            Impact factor:   1.513


  2 in total

1.  Determining a methodology of dosimetric quality assurance for commercially available accelerator-based boron neutron capture therapy system.

Authors:  Katsumi Hirose; Takahiro Kato; Takaomi Harada; Tomoaki Motoyanagi; Hiroki Tanaka; Akihiko Takeuchi; Ryohei Kato; Shinya Komori; Yuhei Yamazaki; Kazuhiro Arai; Noriyuki Kadoya; Mariko Sato; Yoshihiro Takai
Journal:  J Radiat Res       Date:  2022-07-19       Impact factor: 2.438

2.  Dose-Response of TLD-100 in the Dose Range Useful for Hypofractionated Radiotherapy.

Authors:  Raffaele Liuzzi; Consiglia Piccolo; Vittoria D'Avino; Stefania Clemente; Caterina Oliviero; Laura Cella; Mariagabriella Pugliese
Journal:  Dose Response       Date:  2020-02-13       Impact factor: 2.658

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.